Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more
Zhejiang DiAn Diagnostics Co - Asset Resilience Ratio
Zhejiang DiAn Diagnostics Co (300244) has an Asset Resilience Ratio of 3.45% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Zhejiang DiAn Diagnostics Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang DiAn Diagnostics Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥509.56 Million | 3.45% |
| Total Liquid Assets | CN¥509.56 Million | 3.45% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang DiAn Diagnostics Co maintains only 3.45% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang DiAn Diagnostics Co Industry Peers by Asset Resilience Ratio
Compare Zhejiang DiAn Diagnostics Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Zhejiang DiAn Diagnostics Co (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang DiAn Diagnostics Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 2.44% | CN¥384.59 Million | CN¥15.79 Billion | +0.10pp |
| 2023-12-31 | 2.33% | CN¥418.30 Million | CN¥17.94 Billion | +0.19pp |
| 2022-12-31 | 2.14% | CN¥450.09 Million | CN¥21.06 Billion | -0.60pp |
| 2021-12-31 | 2.74% | CN¥427.22 Million | CN¥15.59 Billion | +0.24pp |
| 2020-12-31 | 2.50% | CN¥310.26 Million | CN¥12.40 Billion | -0.23pp |
| 2019-12-31 | 2.73% | CN¥293.24 Million | CN¥10.75 Billion | -- |